Addex Therapeutics Ltd
ADXN · NASDAQ
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Addex Therapeutics Ltd (ADXN) is a Swiss biotechnology company focused on developing innovative drugs for the treatment of neurological and psychiatric disorders. The company leverages advanced technologies targeting allosteric modulation of receptors, enabling it to develop new therapeutic approaches for various conditions such as Parkinson's disease, schizophrenia, and other neurological disorders. Addex Therapeutics is known for its scientific expertise and strong focus on research and development. Addex Therapeutics Ltd (ADXN) shares could be suitable for investors looking for investments in the biotechnology and pharmaceutical research sector with an emphasis on innovative treatment methods.
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy Mark Dyer
Employees
3
Headquarters
Geneva
Upcoming events
Earnings
Upcoming earnings report